Clinical Trials are En Route to Eliminating Inaccuracy and Waste by Leveraging AI and Machine Learning

In the traditional world of drug development, research happens in separate bubbles and exists in silos. Unfortunately, this separation of information slows overall progress and testing. The company VeriSIM Life is utilizing AI and machine learning to combine data and speed up drug development. 

“I always enjoyed challenging problems and how to solve them,” said Dr. Jo Varshney, Founder, and CEO of VeriSIM Life. Dr. Varshney became involved in drug development after feeling limited by the reactiveness of traditional medicine. “Testing in rats and then saying it will work in humans is a hard thing to feel OK about. That caution became a big driving factor in life,” said Dr. Varshney.  

The machine learning from VeriSIM is called BioSIM. It uses existing test results and predicts how different medicines and compounds will impact a test subject. It imitates the biological reality of the living. Dr. Varshney said they try to create virtual imprints of behaviors we see between different animals.  

An integrated approach is critical to rapid drug advances. According to Genetic Engineering and Biotechnology News, “in drug development, speed is cultivating collaborative relationships, enabling data-driven workflows.” With BioSIM, the data is collected, computed, and identifies patterns. The technology leverages the drug development strategy to predict the best next step.  

Even in the earliest stages of development, when there might not be any animal data, the system can predict outcomes based solely on compounds. “What we call the three Rs. Reduction, refinement, and replacement of certain animal experiments,” said Dr. Varshney. “That’s the beauty of machine learning and AI. It’s the computation, learning, and identifying patterns.” 

Follow us on social media for the latest updates in B2B!

Image

Latest

AI Infrastructure
Execution at Scale: How Applied Digital Is Powering AI Infrastructure in Ellendale
July 17, 2025

AI infrastructure is evolving at breakneck speed, and the real challenge is no longer just designing next-generation data centers—it’s executing them at scale. As demand for AI-ready facilities grows, operators must adapt to immense increases in power density, new cooling technologies, and unconventional deployment locations. Power density requirements for AI workloads are pushing the…

Read More
workplace visibility
Workplace Visibility Builds Careers and Communities Through Trust, Recognition, and Shared Growth
July 17, 2025

What if the most powerful way to grow your career isn’t by perfecting your pitch, but by telling your story? In this episode of Professional Quotient: Conversations that Build Equity, host Jason Winningham welcomes Hunter Lopatin, the Director of MarketScale, to explore the real value of visibility and voice in the workplace. The discussion…

Read More
Marketplace Inclusion
How TEKsystems Uses Marketplace Inclusion to Drive Equitable AI Adoption
July 16, 2025

As organizations race to integrate AI into every corner of business, an equally urgent conversation is emerging: How do we ensure this adoption doesn’t widen existing equity gaps? AI is both a disruptive force and an opportunity engine, as recent data shows that AI adoption among HR professionals jumped to 72 percent in 2025, up…

Read More
storytelling
The Secret to Brand Loyalty: Why Storytelling Is the Best Way to Be Heard in a Crowded Market
July 16, 2025

In today’s fast-evolving digital marketplace, attention is scarce, and trust even more so. In an era of remote work, AI-driven marketing, and constant digital noise, storytelling has emerged as one of the most powerful tools to cut through the clutter. In fact, research shows that people who used storytelling techniques to remember information recalled seven…

Read More